null

Purified Anti-Human CD274/PD-L1 Antibody [29E.2A3] (AGEL1646)

SKU:
AGEL1646
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Reactivity:
Human
Applications:
FC
€109 - €199
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Purified Anti-Human CD274/PD-L1 Antibody [29E.2A3]

The Purified Human CD274 (PD-L1) Monoclonal Antibody (29E.2A3) (AGEL1646) is a powerful tool for researchers studying the PD-L1 protein, a key immunomodulatory molecule involved in suppressing the immune response. This monoclonal antibody, produced using innovative purification techniques, exhibits high specificity and sensitivity when detecting human PD-L1, making it a reliable choice for a variety of research applications.PD-L1, also known as programmed death-ligand 1, has garnered significant interest in the field of immuno-oncology for its role in immune evasion and immune tolerance mechanisms exploited by cancer cells. By targeting PD-L1, researchers aim to unravel its intricate involvement in immune checkpoint pathways and explore its potential as a therapeutic target in cancer treatment strategies.

With its ability to selectively bind to PD-L1, the 29E.2A3 monoclonal antibody facilitates precise detection and analysis of PD-L1 expression in diverse experimental settings. Whether investigating PD-L1 levels in tumor cells, evaluating immune checkpoint blockade therapies, or exploring the immune landscape of malignancies, this antibody provides researchers with a valuable tool for advancing their understanding of PD-L1 biology and its implications in cancer immunotherapy.By utilizing the Purified Human CD274 (PD-L1) Monoclonal Antibody (29E.2A3) (AGEL1646), researchers can delve deeper into the complexities of PD-L1-mediated immune regulation and expedite the development of innovative approaches to modulate the immune response for therapeutic benefit in cancer and other immune-related disorders.